ALKS: CFO Granted 158,743 Options and 36,656 RSUs on 10/08/2025
Rhea-AI Filing Summary
Joshua Reed, SVP and Chief Financial Officer, reported equity awards in a Form 4 filed for Alkermes plc (ALKS). On 10/08/2025 he was granted an employee stock option covering 158,743 ordinary shares with an exercise price of $31.51 and a restricted stock unit (RSU) award for 36,656 ordinary shares. Both awards were reported as acquired on the same date and are direct holdings. The option shares vest in four equal annual installments beginning 10/08/2026, and the RSUs vest on the same four-year schedule. Following the transactions, Mr. Reed beneficially owns 158,743 options and 36,656 RSUs. The Form 4 was signed on 10/10/2025.
Positive
- Significant equity grant aligns CFO interests with shareholders via long-term vesting
- Mix of options and RSUs balances upside participation ($31.51 strike) with guaranteed vested value from RSUs
Negative
- Potential future dilution from 158,743 options and 36,656 RSUs if/when vested and exercised
- Concentration of executive compensation tied to equity may increase reported dilution and compensation expense over vesting period
Insights
Grant ties CFO to long-term shareholder value via multi-year vesting.
Equity awards with four-year annual vesting schedules align the executive's compensation with multi-year performance and retention objectives. The grant date of 10/08/2025 and the vesting start of 10/08/2026 create a clear multi-period incentive horizon.
Dependencies include future share-price performance and continued service through each vesting date; these awards do not create immediate dilution but will convert to ordinary shares over time as they vest and options are exercised. Monitor annual vesting cliffs and combined outstanding share impact over the next four years.
Grant size and mix indicate typical senior exec package: options plus RSUs.
The award combines 158,743 options at an exercise price of $31.51 with 36,656 RSUs, a common mix intended to reward upside while providing guaranteed equity value on vesting for retention. The RSUs convert to one ordinary share each upon vesting.
Risks include potential future dilution if options are exercised and timing of recognition for accounting expense. Watch for related disclosures in periodic filings showing share-count and compensation expense over the next fiscal year.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Option (Right to Buy) | 158,743 | $0.00 | -- |
| Grant/Award | Restricted Stock Unit Award | 36,656 | $0.00 | -- |
Footnotes (1)
- Shares underlying the stock option vest and become exercisable in four equal annual installments, commencing on 10/8/2026. Each restricted stock unit represents a contingent right to receive one ordinary share. Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 10/8/2026.
